MX395076B - COMPOSICIÓN A BASE DE UN EXTRACTO DE BIOACTIVO DE L. fermentum PARA USARSE EN EL TRATAMIENTO DE CONDICIONES DERMATOLOGICAS HUMANAS. - Google Patents

COMPOSICIÓN A BASE DE UN EXTRACTO DE BIOACTIVO DE L. fermentum PARA USARSE EN EL TRATAMIENTO DE CONDICIONES DERMATOLOGICAS HUMANAS.

Info

Publication number
MX395076B
MX395076B MX2018000870A MX2018000870A MX395076B MX 395076 B MX395076 B MX 395076B MX 2018000870 A MX2018000870 A MX 2018000870A MX 2018000870 A MX2018000870 A MX 2018000870A MX 395076 B MX395076 B MX 395076B
Authority
MX
Mexico
Prior art keywords
fermentum
dermatological conditions
treatment
composition based
bioactive extract
Prior art date
Application number
MX2018000870A
Other languages
English (en)
Spanish (es)
Other versions
MX2018000870A (es
Inventor
Eva A Berkes
Frederick T Boehm
Nicholas T Monsul
Original Assignee
Quorum Innovations Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Quorum Innovations Llc filed Critical Quorum Innovations Llc
Publication of MX2018000870A publication Critical patent/MX2018000870A/es
Publication of MX395076B publication Critical patent/MX395076B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N63/00—Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
    • A01N63/20—Bacteria; Substances produced thereby or obtained therefrom
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/11—Lactobacillus
    • A23V2400/143—Fermentum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225—Lactobacillus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Mycology (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Genetics & Genomics (AREA)
  • Dermatology (AREA)
  • Agronomy & Crop Science (AREA)
  • Pest Control & Pesticides (AREA)
  • Plant Pathology (AREA)
  • Dentistry (AREA)
  • Environmental Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biochemistry (AREA)
  • Pulmonology (AREA)
  • Hematology (AREA)
MX2018000870A 2015-07-20 2016-07-19 COMPOSICIÓN A BASE DE UN EXTRACTO DE BIOACTIVO DE L. fermentum PARA USARSE EN EL TRATAMIENTO DE CONDICIONES DERMATOLOGICAS HUMANAS. MX395076B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201562194630P 2015-07-20 2015-07-20
PCT/US2016/042939 WO2017015275A1 (en) 2015-07-20 2016-07-19 Materials and methods for improving immune responses and the skin and/or mucosal barrier function

Publications (2)

Publication Number Publication Date
MX2018000870A MX2018000870A (es) 2018-05-15
MX395076B true MX395076B (es) 2025-03-24

Family

ID=57835147

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2018000870A MX395076B (es) 2015-07-20 2016-07-19 COMPOSICIÓN A BASE DE UN EXTRACTO DE BIOACTIVO DE L. fermentum PARA USARSE EN EL TRATAMIENTO DE CONDICIONES DERMATOLOGICAS HUMANAS.

Country Status (17)

Country Link
US (5) US9706778B2 (enExample)
EP (1) EP3324986B1 (enExample)
JP (1) JP6727285B2 (enExample)
KR (1) KR102258415B1 (enExample)
CN (1) CN108135947B (enExample)
AU (1) AU2016297539B9 (enExample)
BR (1) BR112018001187B1 (enExample)
CA (1) CA2991990C (enExample)
DK (1) DK3324986T3 (enExample)
ES (1) ES2904555T3 (enExample)
HU (1) HUE057494T2 (enExample)
IL (1) IL256973B (enExample)
MX (1) MX395076B (enExample)
PL (1) PL3324986T3 (enExample)
PT (1) PT3324986T (enExample)
WO (1) WO2017015275A1 (enExample)
ZA (1) ZA201800209B (enExample)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2463181B (en) 2007-05-14 2013-03-27 Univ New York State Res Found Induction of a physiological dispersion response in bacterial cells in a biofilm
CN108135947B (zh) * 2015-07-20 2022-06-14 群体创新有限责任公司 提高免疫应答和皮肤和/或粘膜屏障功能的材料和方法
WO2018146550A1 (en) 2017-02-10 2018-08-16 De Maio Domingos Mauricio Methods and systems for preventing, correcting, transforming, and modifying facial, aesthetics, and consulting patients regarding the same
US11400037B2 (en) * 2017-03-10 2022-08-02 Johnson & Johnson Consumer Inc. Composition having reduced residue
GB201807576D0 (en) 2018-05-09 2018-06-20 Skinbiotherapeutics Plc Compositions and uses thereof
US11541105B2 (en) 2018-06-01 2023-01-03 The Research Foundation For The State University Of New York Compositions and methods for disrupting biofilm formation and maintenance
EP3685669A1 (en) * 2019-01-23 2020-07-29 Chrisal NV Composition for the decontamination and inoculation of surfaces
EP3741398A1 (en) * 2019-05-20 2020-11-25 Medizinische Hochschule Hannover Method for coating a medical device and coated medical device
KR20220118438A (ko) * 2019-11-26 2022-08-25 쿼럼 이노베이션즈 엘엘씨 신규한 보호 장벽 조성물 및 그의 용도
CN115776986A (zh) * 2020-05-06 2023-03-10 群体创新有限责任公司 新型蛋白质及其治疗和美容用途
KR102167387B1 (ko) 2020-05-14 2020-10-19 코스맥스 주식회사 피부 장벽 강화, 피부 보습 또는 항노화를 위한 조성물
WO2021248111A1 (en) * 2020-06-06 2021-12-09 Quorum Innovations, Llc Materials and methods for inhibiting a viral infection, including a coronavirus infection
CA3193765A1 (en) * 2020-09-29 2022-04-07 Anindya Dasgupta A personal care composition comprising amino acids
KR102573754B1 (ko) * 2021-02-25 2023-09-01 주식회사 차메디텍 신규의 펩타이드 및 이를 포함하는 피부장벽 강화 또는 피부가려움증 억제를 위한 화장료 조성물
KR102389749B1 (ko) * 2021-05-14 2022-04-22 주식회사 세바바이오텍 피부장벽강화 및 항주름 활성을 갖는 피부 유래 락토바실러스 퍼멘텀 아종 세바­１０１ 균주 및 이의 용도
CN113832050B (zh) * 2021-08-13 2022-10-21 广东省科学院微生物研究所(广东省微生物分析检测中心) 一株高效合成烟酰胺、抗光老化的发酵乳杆菌xjc60及其应用
CN114717162A (zh) * 2022-05-17 2022-07-08 廖梅香 发酵乳杆菌及其应用
CN118126875B (zh) * 2024-02-05 2024-11-05 中山大学肿瘤防治中心（中山大学附属肿瘤医院、中山大学肿瘤研究所） 一株表皮葡萄球菌及其应用

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPS057102A0 (en) * 2002-02-15 2002-03-07 Vri Biomedical Ltd Compositions and methods for treatment of skin disorders
WO2005009342A2 (en) * 2003-07-16 2005-02-03 Pharmacia Corporation Method for the treatment or prevention of dermatological disorders with a cyclooxygenase-2 inhibitor alone and in combination with a dermatological treatment agent and compositions therewith
EP1736537A1 (en) * 2005-06-22 2006-12-27 OrganoBalance GmbH Methods and means for protecting the skin against pathogenic microorganisms
JP2007284360A (ja) * 2006-04-13 2007-11-01 Mitsukan Group Honsha:Kk 乳酸菌由来のｐｐａｒ依存的遺伝子転写活性化組成物
BRPI0719431A2 (pt) * 2006-12-01 2013-12-03 Organobalance Gmbh Composição, kit, uso de uma combinação de microorganismo, e, método para a produção da composição ou do kit.
EP2227239A2 (en) * 2007-12-06 2010-09-15 Arla Foods Amba Probiotic bacteria and regulation of fat storage
CZ2009724A3 (cs) * 2009-11-04 2011-02-09 Bio Agens Research And Development - Bard, S.R.O. Protiplísnová smes s houbovým organismem Pythium oligandrum
CN103025328A (zh) * 2010-04-16 2013-04-03 达沃斯生命科学有限公司 用于皮肤应用的至少一种维生素e成分和酪氨酸酶抑制剂协同相互作用
JP6149279B2 (ja) * 2011-02-09 2017-06-21 オーガノバランス ゲーエムベーハー 皮膚状態の治療に使用するためのペプチド
CN103687604A (zh) 2011-03-01 2014-03-26 群体创新有限责任公司 用于治疗与致病生物膜相关之病症的材料和方法
CN102226157B (zh) * 2011-05-06 2013-01-09 北京龙科方舟生物工程技术有限公司 一株发酵乳杆菌及其应用
CN104010648A (zh) * 2011-12-07 2014-08-27 可尔必思株式会社 包含乳酸菌或其处理物的脂质代谢和/或糖代谢改善剂
CN108135947B (zh) * 2015-07-20 2022-06-14 群体创新有限责任公司 提高免疫应答和皮肤和/或粘膜屏障功能的材料和方法

Also Published As

Publication number Publication date
CA2991990C (en) 2024-04-16
US9706778B2 (en) 2017-07-18
US10617726B2 (en) 2020-04-14
HUE057494T2 (hu) 2022-05-28
JP6727285B2 (ja) 2020-07-22
CN108135947A (zh) 2018-06-08
US20170224748A1 (en) 2017-08-10
DK3324986T3 (da) 2022-01-31
CA2991990A1 (en) 2017-01-26
PT3324986T (pt) 2022-01-26
WO2017015275A1 (en) 2017-01-26
US20200215130A1 (en) 2020-07-09
BR112018001187A2 (pt) 2018-09-11
BR112018001187B1 (pt) 2022-02-15
US20170020139A1 (en) 2017-01-26
IL256973B (en) 2020-06-30
EP3324986A4 (en) 2019-01-09
JP2018527322A (ja) 2018-09-20
EP3324986B1 (en) 2021-11-24
AU2016297539A1 (en) 2018-02-08
KR20180023012A (ko) 2018-03-06
MX2018000870A (es) 2018-05-15
CN108135947B (zh) 2022-06-14
US10004772B2 (en) 2018-06-26
ES2904555T3 (es) 2022-04-05
US11564957B2 (en) 2023-01-31
EP3324986A1 (en) 2018-05-30
AU2016297539B9 (en) 2019-11-28
PL3324986T3 (pl) 2022-04-04
HK1253067A1 (zh) 2019-06-06
IL256973A (en) 2018-03-29
US20170296599A1 (en) 2017-10-19
AU2016297539B2 (en) 2019-10-31
KR102258415B1 (ko) 2021-05-28
ZA201800209B (en) 2018-12-19
US12440521B2 (en) 2025-10-14
US20230165915A1 (en) 2023-06-01

Similar Documents

Publication Publication Date Title
MX395076B (es) COMPOSICIÓN A BASE DE UN EXTRACTO DE BIOACTIVO DE L. fermentum PARA USARSE EN EL TRATAMIENTO DE CONDICIONES DERMATOLOGICAS HUMANAS.
PH12019501575A1 (en) ISOFORM-SPECIFIC, CONTEXT-PERMISSIVE TGFá1 INHIBITORS AND USE THEREOF
PH12017501611A1 (en) Fluorinated lysyl oxidase-like 2 inhibitors and uses thereof
EP3536168A3 (en) Probiotic formulations and methods for use
AR110684A1 (es) Composiciones que comprenden cepas bacterianas y método de tratamiento
MX2016012574A (es) Compuestos heteroarilo sustituidos y metodos de uso.
WO2016086210A8 (en) Probiotic and prebiotic compositions, and methods of use thereof for treatment and prevention of graft versus host disease
MX2020005446A (es) Metodos para marcar una molecula deuterada o no deuterada y formulaciones farmaceuticas para tratamiento.
EP4252851A3 (en) Ezh2 inhibitors for treating lymphoma
AR101072A1 (es) Extracto de fermento de una cepa bacteriana para el aumento de los niveles de adiponectina
MX2018004616A (es) Cosmetica qie tiene bacterias probioticas.
MX395525B (es) Composiciones inmunogenicas para usar en vacunas neumococicas.
TW201613919A (en) Inhibitors of Bruton's tyrosine kinase
PH12017500494A1 (en) Methyl-and trifluoromethyl-substituted pyrrolopyridine modulators of rorc2 and methods of use thereof
MD20160007A2 (ro) Inhibitori ai RORC2 şi metode de utilizare a acestora
MX2017000394A (es) Vacunas para virus influenza y usos de las mismas.
MX390493B (es) Composiciones que comprenden celulas germinales mesenquimales y usos de las mismas
EP4289820A3 (en) Compounds for use in treating alzheimer's disease in apoe4+/+ patients
MA43650B1 (fr) Formulations/compositions comprenant un inhibiteur de btk
MX379359B (es) Derivados de 8-amino-2-oxo-1,3-diaza-espiro-[4.5]-decano.
MX2018000262A (es) Usos terapeuticos de formulaciones de berberina.
MX2016009241A (es) Metodos para reducir el mal olor y las bacterias.
MX2020001632A (es) Composiciones que comprenden cepas bacterianas.
BR112017009510A2 (pt) composições compreendendo ciclosporina
MX379201B (es) Derivados de 3-(carboxietil)-8-amino-2-oxo-1,3-diaza-espiro-[4.5]-decano.